Mark A. Currier
Impact in
Papers in
- Co-authors
- Timothy P. Cripe (32 shared papers)Margaret H. Collins (7 shared papers)Yonatan Y. Mahller (4 shared papers)Lisa C. Adams (3 shared papers)John M. Racadio (3 shared papers)Alexander J. Towbin (3 shared papers)James I. Geller (3 shared papers)Keri A. Streby (4 shared papers)
- Journals
- Molecular Therapy (6 papers)Molecular Therapy — Oncolytics (3 papers)Journal of Pediatric Hematology/Oncology (2 papers)Gene Therapy (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
Mark A. Currier
31 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 55
- Genetics 710
- Oncology 624
- Biotechnology 96
- Immunology 153
- Neurology 99
Countries citing papers authored by Mark A. Currier
This map shows the geographic impact of Mark A. Currier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Currier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Currier more than expected).
Fields of papers citing papers by Mark A. Currier
This network shows the impact of papers produced by Mark A. Currier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Currier. The network helps show where Mark A. Currier may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Currier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 125 | |
| 2 | Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells. | 2001 | 120 |
| 3 | 2017 | 109 | |
| 4 | 2007 | 76 | |
| 5 | 2009 | 75 | |
| 6 | 2008 | 57 | |
| 7 | 2019 | 49 | |
| 8 | 2018 | 44 | |
| 9 | 2005 | 37 | |
| 10 | 2017 | 36 | |
| 11 | 2013 | 34 | |
| 12 | 2004 | 34 | |
| 13 | 2010 | 32 | |
| 14 | 2014 | 31 | |
| 15 | 2002 | 31 | |
| 16 | 2017 | 25 | |
| 17 | 2014 | 23 | |
| 18 | 2002 | 14 | |
| 19 | 2023 | 12 | |
| 20 | 2012 | 11 |
About Mark A. Currier
Mark A. Currier is a scholar working on Genetics, Oncology, Molecular Biology, Epidemiology and Immunology, having authored 32 papers that have together received 1.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (26 papers), CAR-T cell therapy research (18 papers), Herpesvirus Infections and Treatments (8 papers), Neuroblastoma Research and Treatments (5 papers), RNA Interference and Gene Delivery (5 papers), Cytomegalovirus and herpesvirus research (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Genetics (710 citations), Oncology (624 citations), Biotechnology (96 citations), Immunology (153 citations) and Neurology (99 citations). Mark A. Currier has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Timothy P. Cripe, Margaret H. Collins, Yonatan Y. Mahller, Lisa C. Adams, John M. Racadio, Alexander J. Towbin, James I. Geller, Keri A. Streby, Joe Conner and Rebecca A. Gillespie. Their work appears in journals such as Molecular Therapy, Molecular Therapy — Oncolytics, Journal of Pediatric Hematology/Oncology, Gene Therapy and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.